Vaxart Inc - Company Profile
Powered by 
All the sales intelligence you need on Vaxart Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Vaxart Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Vaxart Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Vaxart Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220378944A1 | Application | FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS | A61K39/12; A61K48/0058; A61K9/0053; A61K9/2009; A61K9/2054; A61K9/2059; A61K9/2813; A61K9/282; A61K9/2846; C12N2710/10341; C12N2710/10343; C12N2760/18534; C12N2770/16034 | December 01, 2022 |
| US11433146B2 | Grant | Formulations for small intestinal delivery of RSV and norovirus antigens | A61K39/12; A61K48/0058; A61K9/0053; A61K9/2009; A61K9/2054; A61K9/2059; A61K9/2813; A61K9/282; A61K9/2846; C12N2710/10341; C12N2710/10343; C12N2760/18534; C12N2770/16034 | September 06, 2022 |
| WO2022165360A3 | Application | CHIMERIC ADENOVIRAL VECTORS | C12N15/86 | September 01, 2022 |
| WO2022165360A2 | Application | CHIMERIC ADENOVIRAL VECTORS | August 04, 2022 | |
| WO2021248017A3 | Application | CHIMERIC ADENOVIRAL VECTORS | A61K2039/53; A61K2039/543; A61K2039/572; A61K39/12; A61P31/14; C12N15/86; C12N2710/10343; C12N2770/20022; C12N2770/20034 | January 06, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer